
Tempus AI (NASDAQ: TEM) appears to be a smart buy for tech traders as it is a leading provider of AI-enabled services and infrastructure for healthcare, and its stock is set up to rebound robustly. Trading near 52-week lows in late February, the stock is more than 45% below the analysts' consensus, with tailwinds to drive it there.
Among them are outperformance, better-than-expected guidance, and internal metrics that point not only to improving client counts, but also to an enviable penetration rate.